AB
Ashok Bhati
About Ashok Bhati
Data last updated:
Ashok Bhati is a Director at Ambumed Pharma Private Limited (since 2024). The company operates in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ambumed Pharma Private Limited U21001TS2024PTC183695 | Director | 22 Mar 2024 | 2024 | Active |
Board colleagues of Ashok Bhati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dinesh Bhati | 11159242 | Ambumed Pharma Private Limited | Director |
| Mahesh Kumar Toshniwal | 10562219 | Ambumed Pharma Private Limited | Director |
| Manoj Kumar Bhati | 11158066 | Ambumed Pharma Private Limited | Director |
| Pradeep Kumar Sharma | 00285028 | Ambumed Pharma Private Limited | Director |
| Radheshyam Bhati | 10645945 | Ambumed Pharma Private Limited | Individual Subscriber |
| Ram Kumar Bhati | 10663474 | Ambumed Pharma Private Limited | Director |
| Ramswaroop Darak | 10642984 | Ambumed Pharma Private Limited | Director |
| Shri Niwas Bhati | 10562218 | Ambumed Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashok Bhati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashok Bhati
Ashok Bhati currently holds 1 directorship: Ambumed Pharma Private Limited (Director, since 22 Mar 2024).
Ashok Bhati was first appointed on 22 Mar 2024 as Director at Ambumed Pharma Private Limited.
The current boards of Ashok Bhati's companies include Dinesh Bhati (Ambumed Pharma Private Limited), Mahesh Kumar Toshniwal (Ambumed Pharma Private Limited), Manoj Kumar Bhati (Ambumed Pharma Private Limited), Pradeep Kumar Sharma (Ambumed Pharma Private Limited), Radheshyam Bhati (Ambumed Pharma Private Limited), Ram Kumar Bhati (Ambumed Pharma Private Limited), among others.